High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors

There are currently no established second- and later-line therapies for postmenopausal women with hormone receptor-positive advanced or metastatic breast cancer. We examined the efficacy of high-dose toremifene (HD-TOR) for this patient group and whether aromatase inhibitor (AI) resistance influence...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Breast Cancer
Päätekijät: Fushimi, Atsushi, Tabei, Isao, Fuke, Azusa, Okamoto, Tomoyoshi, Takeyama, Hiroshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7037483/
https://ncbi.nlm.nih.gov/pubmed/32099680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7156574
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia